Single-cell RNA sequencing (scRNA-seq) of sorted CD45+ tumor-infiltrating immune cells was conducted on D14 following IT CXCL9/10-DC and i.p. anti-PD-1 as monotherapies or in combination. This evidence concerns the gene CXCL9 and neoplasm.